WHO and Eli Lilly issue global warning about fake weight-loss drugs

The World Health Organization and Eli Lilly and Co. are warning about fake versions of weight-loss and diabetes medicines, including semaglutide and tirzepatide. These fake drugs are being sold online and pose health risks. Patients are advised to only buy medications from licensed physicians and avoid unfamiliar sources. Novo Nordisk has also issued similar warnings in the past. Lilly emphasized that products marketed as tirzepatide but not Mounjaro or Zepbound are not approved by the FDA. The WHO has issued a global alert about fake versions of Ozempic, a popular weight-loss drug that is also used to treat type 2 diabetes. The fake medicines could be harmful to health, and obtaining them from illegal online sources increases the risk of using falsified or unlicensed products. Lilly is taking legal action against entities selling products claiming to contain tirzepatide. Patients are urged to be cautious and only obtain medications from legitimate sources.